Institutional Manager · CIK 0002013341
Foresite Capital Management VI LLC
Larkspur, CA · File #028-25267
Latest AUM
$330.8M
Positions
12
Top-10 Concentration
94.9%
Filings
5
Portfolio Value Over Time
2024-12
2025-03
2025-06
2025-09
2025-12
Biggest QoQ Changes
Ranked by conviction flow (share change × current price) so mark-to-market moves don't dominate. Price effect column shows how much of the $ change was just the stock moving.
| Action | Issuer | Ticker / CUSIP | Δ Shares | Flow ($) | Price Effect |
|---|---|---|---|---|---|
| NEW | Natera, Inc. | NTRA | +67,356 | +$15.4M | $0 |
| NEW | AGIOS PHARMACEUTICALS, INC. | AGIO | +530,000 | +$14.4M | $0 |
| EXITED | Akero Therapeutics, Inc. | 00973Y108 | -244,900 | -$11.6M | $0 |
| NEW | Atai Beckley N.V. | N0731H103 | +2,750,000 | +$11.2M | $0 |
| ADD | Verastem, Inc. | VSTM | +520,000 | +$4.0M | -$2.9M |
| REDUCE | Corvus Pharmaceuticals, Inc. | CRVS | -350,000 | -$2.7M | +$571,307 |
| EXITED | Avidity Biosciences, Inc. | 05370A108 | -40,000 | -$1.7M | $0 |
| EXITED | CASI Pharmaceuticals, Inc. | G1933S101 | -979,956 | -$1.6M | $0 |
| ADD | Centessa Pharmaceuticals plc | CNTA | +50,000 | +$1.3M | +$998,654 |
| REDUCE | ALUMIS INC. | ALMS | 0 | $0 | +$24.5M |
Sector Allocation
Filing History
- 13F HOLDINGS REPORTQ/E Dec 202512 pos · $330.8M
- 13F HOLDINGS REPORTQ/E Sep 202512 pos · $258.9M
- 13F HOLDINGS REPORTQ/E Jun 202520 pos · $177.9M
- 13F HOLDINGS REPORTQ/E Mar 202514 pos · $182.5M
- 13F HOLDINGS REPORTQ/E Dec 202414 pos · $224.4M
Top 12 Holdings — Dec 2025
| # | Issuer | Ticker | Shares | Value | % of Portfolio |
|---|---|---|---|---|---|
| 1 | CG Oncology, Inc. | CGON | 2,221,474 | $92.2M | 27.88% |
| 2 | RAPT Therapeutics, Inc. | 75382E208 | 1,562,500 | $52.9M | 16.00% |
| 3 | ALUMIS INC. | ALMS | 4,247,670 | $41.5M | 12.53% |
| 4 | Centessa Pharmaceuticals plc | CNTA | 1,364,019 | $34.1M | 10.31% |
| 5 | Verastem, Inc. | VSTM | 3,135,120 | $24.2M | 7.32% |
| 6 | Denali Therapeutics Inc. | DNLI | 1,000,000 | $16.5M | 4.99% |
| 7 | Natera, Inc. | NTRA | 67,356 | $15.4M | 4.66% |
| 8 | AGIOS PHARMACEUTICALS, INC. | AGIO | 530,000 | $14.4M | 4.36% |
| 9 | Kymera Therapeutics, Inc. | KYMR | 146,332 | $11.4M | 3.44% |
| 10 | Atai Beckley N.V. | N0731H103 | 2,750,000 | $11.2M | 3.40% |
| 11 | Corvus Pharmaceuticals, Inc. | CRVS | 1,381,233 | $10.6M | 3.21% |
| 12 | Hinge Health, Inc. | HNGE | 135,000 | $6.3M | 1.90% |